at MarketWatch.com (Jun 6, 2014)
Cardiovascular Systems (CSII +4%) gains this morning after pricing its 2M secondary offering at $17.60, just a mere a 1% discount to Tuesday's close. The medical device company, says it wants to use the proceeds for working capital and general corporate needs - which likely includes further funding of its Orbit II trials, a treatment therapy for severely calcified coronary lesions. The company's current float is around 21.1M shares.
From other sites